Mainstreaming Addiction Treatment Act of 2019
Latest action · Jul 10, 2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 10, 2019
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Mainstreaming Addiction Treatment Act of 2019
This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).
Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity.
The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.
Cosponsors 5
Members who signed on, in the order they did. Signatures ran from Jul 10, 2019 to Oct 25, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-AK | Lisa Murkowski | Original | Jul 10, 2019 |
| R-AK | Dan Sullivan | Jul 29, 2019 | |
| D-CO | Michael F. Bennet | Sep 23, 2019 | |
| D-OR | Jeff Merkley | Oct 16, 2019 | |
| R-MS | Cindy Hyde-Smith | Oct 25, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Jul 10, 2019 |
Actions 2
Everything that happened, newest first.
- Jul 10, 2019Introduced in Senate
- Jul 10, 2019Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 445 | Mainstreaming Addiction Treatment Act of 2021 | Reintroduced Bill | Feb 25, 2021 |
| HR 2482 | Mainstreaming Addiction Treatment Act of 2019 | Related bill | May 31, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.
- Short Title(s) as Introduced
- Mainstreaming Addiction Treatment Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Commerce.
- Administrative law and regulatory procedures
- Commerce
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Federal preemption
- Government information and archives
- Health care coverage and access
- Health personnel
- Licensing and registrations
- Prescription drugs
- State and local government operations
Text 1
Each version as it was printed, newest first.
- Jul 10, 2019Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.